Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
Doctor Gives Cutting-Edge HIV Treatment to SF’s Most Vulnerable
24 March 2023
Doctor Gives Cutting-Edge HIV Treatment to SF’s Most Vulnerable
24 March 2023
Sanofi gets FDA nod for long-acting haemophilia A drug
03 March 2023
Long-Acting Glatiramer Acetate Appears Safe and Effective in Large Trial
03 March 2023
Long-Acting ART Suppresses HIV in Individuals Without Virological Suppression
03 March 2023
Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option
03 March 2023
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
24 February 2023
PrEP implant could enable long-term HIV protection
24 February 2023
Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366, a Long-Acting HSV-2 Helicase Inhibitor Targeting High-Recurrence Genital Herpes
17 February 2023
Newer stories
Older Stories